2017Lung CancerRequires access

Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy

Roberta Minari, Paola Bordi, Marzia Del Re, Francesco Facchinetti, Francesca Mazzoni, Fausto Barbieri, Andrea Camerini, Camilla Comin, Letizia Gnetti, Cinzia Azzoni, Rita Nizzoli, Beatrice Bortesi, Eleonora Rofi, Paolo Petreni, Nicoletta Campanini, Giulio Rossi, Romano Danesi, Marcello Tiseo

Open publisher page 109 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 109 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Osimertinib, T790M, Medicine, Liquid biopsy, Lung cancer, Biopsy, Oncology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy — Research Paper | ScholarLens